The Pathophysiological Role of the Serotonergic System in Tourette Syndrome

Author: Muller-Vahl, Kirsten R.

Source: Current Psychiatry Reviews, Volume 3, Number 4, November 2007 , pp. 271-276(6)

Publisher: Bentham Science Publishers

Abstract:

Tourette syndrome (TS) is defined as a chronic motor and vocal tic disorder. Because dopamine blocking drugs reduce tics it has been suggested that the dopaminergic system is pathophysiologically involved. However, comorbidities such as obsessive-compulsive behavior (OCB), depression, and anxiety are often associated suggesting that imbalances among other neurotransmitter systems may also exist. An increasing body of evidence points to an involvement of the serotonergic system. Serotonin reuptake inhibitors are effective in the treatment of comorbid OCB, depression, and anxiety. Levels of serotonin (5-hydroxytryptamine; 5-HT), the primary metabolite 5-hydroxyindoleacetic acid (5-HIAA), and tryptophan, respectively, have been found to be reduced not only in blood and CSF but also in different brain regions. In addition, neuroimaging studies demonstrated a significant reduction in serotonin transporter binding ratios in TS compared to controls. In addition, alterations in 5-HT2A receptor binding and tryptophan metabolism have been demonstrated. Recent genetic studies suggested a pathogenetic role of polymorphic variation(s) of the novel 5-HT synthesizing enzyme tryptophan hydroxylase 2 (TPH2) in TS. In summary, several findings from clinical, laboratory, neuroimaging and genetic studies strongly support the etiological relevance of the serotonergic system in TS.

Keywords: Tourette syndrome; tics; obsessive-compulsive disorder; serotonin; tryptophan; 5-hydoxyindoleacetic acid

Document Type: Research article

Publication date: 2007-11-01

More about this publication?

• Current Psychiatry Reviews publishes frontier reviews on all the latest advances on clinical psychiatry and its related areas e.g. pharmacology, epidemiology, clinical care, and therapy. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all clinicians, psychiatrists and researchers in psychiatry.

Related content

• In this: publication
• By this: publisher
• In this Subject: Neurology & Psychiatry ,  Psychology/Psychiatry
• By this author: Muller-Vahl, Kirsten R.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers